Amlodipine besylate and benazepril hydrochloride - Amlodipine besylate and benazepril hydrochloride
Navigation: NDC > Supplier starting with: W > WATSON LABORATORIES, INC.| Field | Value |
|---|---|
| NDC Code: | 0591-3757 |
| Proprietary Name: | Amlodipine besylate and benazepril hydrochloride |
| Suffix: | |
| Non-Proprietary Name: | Amlodipine besylate and benazepril hydrochloride |
| Dosage Form: | CAPSULE |
| Method: | ORAL |
| Original Marketing Date: | 13-10-2010 |
| Category Name: | ANDA |
| Application Number: | ANDA077890 |
| Labeler: | WATSON LABORATORIES, INC. |
| Substance Name: | AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE |
| Active Numerator Strength: | 2.5; 10 |
| Active Ingredient Unit: | mg/1; mg/1 |
| Pharm Classes: | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient],Angiontensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE] |
| DEA Schedule: |